Spinraza (nusinersen)
Spinraza 12 MG in 5 ML Injection
NO BOXED WARNING
Dosage & Administration
Dosage & Administration
drug label
Spinraza Prescribing Information
pharmacy
Spinraza Preferred Pharmacy
Financial Assistance
Financial Assistance Programs
Spinraza retails for $29,044 per dose without insurance or financial assistance.Depending on your patient's insurance situation and other eligibility criteria, they may be able to get Spinraza for significantly less. Review the program information below to determine what program can offer your patient the most benefits.Copay Card Program$0 Copay
Available for
commercial
Forms
patient education
Spinraza Patient Education
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link
Patient toolkit
people also ask
Spinraza FAQs
8.1 PregnancyThere is insufficient data regarding the developmental risk of using SPINRAZA in pregnant women. Animal studies showed developmental toxicity (long-term neurobehavioral impairment) at all tested doses. The background risk of birth defects and miscarriage in the indicated population is unknown.
8.2 LactationThere is no data on nusinersen presence in human milk or its effects on breastfed infants. Nusinersen was found in the milk of lactating mice when given by injection. The decision to breastfeed should consider both the benefits of breastfeeding and the mother's clinical need for SPINRAZA, weighing any potential adverse effects.
8.4 Pediatric UseSPINRAZA's safety and effectiveness have been established in pediatric patients from newborn to 17 years old based on clinical studies.
8.5 Geriatric UseClinical studies of SPINRAZA did not sufficiently include subjects aged 65 and over to determine potential differences in response compared to younger subjects.
FAQ Data Source